What is SiriusPoint Ltd.'s earnings per share (EPS)?

SiriusPoint Ltd. (SPNT) reported diluted earnings per share of $3.64 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

SiriusPoint Ltd. (SPNT) Financials

SPNT

Trailing 12 months to June 30, 2026

Revenue $3.2B +22.6% YoY

Net Income $506.0M +335.8% YoY

EPS (Diluted) $4.06 +327.4% YoY

Operating Cash Flow $265.9M +91.3% YoY

Market Cap $2.9B as of Oct 8, 2026

Price / Sales 0.9x on $3.2B revenue, trailing 12 months to June 30, 2026

Price / Earnings 5.7x on $506.0M net income, trailing 12 months to June 30, 2026

Price / Book 1.3x on $2.3B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 8, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 29, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SPNT SEC filings page.

SiriusPoint Ltd. (SPNT) reported $3.2B in revenue over the twelve months to Jun 30, 2026, up 22.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SPNT FY2025 2026-10-03

SiriusPoint’s profit recovery is not yet translating into comparable cash generation, while share reductions amplify per-share results.

In FY2025, net income of $460M was 4.5x operating cash flow, revealing that reported earnings converted into cash only partially. The same gap was narrower in FY2024, when the ratio was 2.7x, so the recovery in accounting profit outpaced cash conversion.

Liabilities represented 80.3% of assets in FY2025, while debt-to-equity was 0.3x, indicating that the balance sheet is funded mainly through obligations beyond traditional long-term debt. That structure makes financial resilience more dependent on the quality and liquidity of the asset base than on debt levels alone.

Revenue increased 23.1% in FY2025 while net income increased 130.0%, so earnings recovery outpaced top-line growth rather than simply reflecting more volume. The share count fell 27.9% as FY2025 buybacks reached $491M, meaning per-share results benefited from both higher profit and fewer shares.

Financial Health Signals

Financial Health Score 34/100

Scored as: Insurers peer group

Scored against insurers for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of SiriusPoint Ltd.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Loss Ratio

Loss Ratio measures the claims an insurer paid out against the premiums it earned, so a lower ratio leaves more of every premium dollar with the company. SiriusPoint Ltd. scores 64/100 on it among other insurers.

Premium Growth

SiriusPoint Ltd. reported revenue of $3.2B in fiscal year 2025, against $2.6B in fiscal year 2024. Premium Growth ranks insurers on the three-year path of the premiums they write rather than on total revenue, and SiriusPoint Ltd. scores 49/100 among other insurers.

Capital

SiriusPoint Ltd. funded 19.6% of its assets with shareholders' equity at the end of fiscal year 2025, holding $2.5B of equity against $12.6B of assets. Capital ranks insurers on that cushion, and SiriusPoint Ltd. scores 35/100 among other insurers.

Investment Yield

Not available for SiriusPoint Ltd., and counted as zero in the overall score.

Combined Ratio

Combined Ratio puts claims and running costs together against premiums earned, and a figure under 100% means the underwriting made money before any investment income was counted. SiriusPoint Ltd. scores 41/100 on it among other insurers.

Stability

SiriusPoint Ltd. reported net income of $460.0M in fiscal year 2025, against $200.0M in fiscal year 2024. Stability ranks insurers on how steady net income has been across five years, and SiriusPoint Ltd. scores 16/100 among other insurers.

Piotroski F-Score Partial

5/7

SiriusPoint Ltd. passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality

0.22x

For every $1 of reported earnings, SiriusPoint Ltd. generates $0.22 in operating cash flow ($102.4M OCF vs $460.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$744.1M

YoY-0.5%

QoQ-3.9%

5Y CAGR+5.8%

SiriusPoint Ltd. generated $744.1M in revenue in Q2 2026. This represents a decrease of 0.5% from the same quarter a year earlier. Against the prior quarter it is down 3.9%.

Net Income

$68.6M

YoY+8.5%

QoQ-32.9%

5Y CAGR0.0%

10Y CAGR+2.5%

SiriusPoint Ltd. reported $68.6M in net income in Q2 2026. This represents an increase of 8.5% from the same quarter a year earlier. Against the prior quarter it is down 32.9%.

EPS (Diluted)

$0.58

YoY+16.0%

QoQ-29.3%

5Y CAGR+9.4%

10Y CAGR+1.3%

SiriusPoint Ltd. earned $0.58 per diluted share (EPS) in Q2 2026. This represents an increase of 16.0% from the same quarter a year earlier. Against the prior quarter it is down 29.3%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt

$614.8M

YoY-16.1%

QoQ-28.3%

5Y CAGR-9.9%

10Y CAGR+56.4%

SiriusPoint Ltd. held $614.8M in cash against $675.5M in long-term debt as of Q2 2026.

Shares Outstanding

116M

YoY-0.5%

QoQ-1.2%

5Y CAGR-6.4%

10Y CAGR+0.9%

SiriusPoint Ltd. had 116M shares outstanding in Q2 2026. This represents a decrease of 0.5% from the same quarter a year earlier. Against the prior quarter it is down 1.2%.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Net Margin

9.2%

YoY+0.8pp

QoQ-4.0pp

5Y change-3.0pp

SiriusPoint Ltd.'s net profit margin was 9.2% in Q2 2026, showing the share of revenue converted to profit. This is up 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.0 percentage points.

Return on Equity

3.0%

YoY0.0pp

QoQ-1.4pp

5Y change+0.4pp

10Y change-0.9pp

SiriusPoint Ltd.'s ROE was 3.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. That is unchanged from the same quarter a year earlier. Against the prior quarter it is down 1.4 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks

$51.4M

QoQ+134.7%

SiriusPoint Ltd. spent $51.4M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. Against the prior quarter it is up 134.7%.

R&D Spending

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

SPNT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SPNT quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$3.2B	$3.2B+23.1%	$2.6B-4.9%	$2.7B+30.0%	$2.1B-3.4%	$2.2B+145.1%	$889.7M-9.5%	$982.6M+165.6%	$370.0M-60.6%	$939.0M+36.3%	$689.0M+19.9%	$574.8M+8.4%	$530.1M+10.7%	$478.8M+105.2%	$233.3M	$0
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	$61.4M+14.3%	$53.8M+48.3%	$36.2M-31.8%	$53.1M+34.9%	$39.4M-14.5%	$46.0M+15.1%	$40.0M+21.1%	$33.0M+20.7%	$27.4M+2322.7%	$1.1M
Interest Expense	$76.0M	$79.7M+14.5%	$69.6M+8.6%	$64.1M+66.1%	$38.6M+13.5%	$34.0M+314.6%	$8.2M0.0%	$8.2M-0.3%	$8.2M0.0%	$8.2M-0.1%	$8.2M+13.8%	$7.2M	$0	$0	N/A	N/A
Income Tax	$91.3M	$81.2M+164.5%	$30.7M+168.2%	-$45.0M-22.6%	-$36.7M-243.0%	-$10.7M-232.1%	$8.1M+1057.1%	$700K+117.5%	-$4.0M-133.5%	$12.0M+114.1%	$5.6M+292.5%	-$2.9M-151.4%	$5.6M	$0	$0	N/A
Net Income	$506.0M	$460.0M+130.0%	$200.0M-43.7%	$355.0M+191.7%	-$387.0M-767.2%	$58.0M-59.6%	$143.5M-28.5%	$200.6M+163.1%	-$317.7M-214.4%	$277.8M+905.2%	$27.6M+131.6%	-$87.4M-273.4%	$50.4M-77.8%	$227.3M+128.7%	$99.4M+8896.5%	-$1.1M
EPS (Basic)	N/A	$3.80+258.5%	$1.06-45.1%	$1.93+176.9%	-$2.51-996.4%	$0.28-81.8%	$1.54-29.4%	$2.18+166.7%	-$3.27-220.7%	$2.71+942.3%	$0.26+131.0%	-$0.84-275.0%	$0.48-81.4%	$2.58+104.8%	$1.26	N/A
EPS (Diluted)	$4.06	$3.64	$1.04-43.8%	$1.85+173.7%	-$2.51-1029.6%	$0.27	$1.53-29.2%	$2.16+166.1%	-$3.27-223.9%	$2.64+915.4%	$0.26+131.0%	-$0.84-278.7%	$0.47-81.5%	$2.54+101.6%	$1.26	N/A
Diluted Shares (Avg)	N/A	122M	169M-0.1%	170M+5.9%	160M+6.7%	150M	93M+0.3%	93M-4.5%	97M-7.8%	105M-0.3%	106M+1.5%	104M-2.2%	106M+19.6%	89M+13.2%	79M	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$744.1M-0.5%	$774.6M+6.5%	$973.7M+58.9%	$755.9M+34.5%	$748.2M+0.7%	$727.3M+6.1%	$612.8M-5.1%	$562.2M-20.0%
Interest Expense	$18.7M-11.4%	$16.8M-7.2%	$19.5M-0.5%	$21.0M+52.2%	$21.1M+34.4%	$18.1M-11.7%	$19.6M-1.0%	$13.8M-30.3%
Income Tax	$15.8M+36.2%	$19.2M+44.4%	$36.1M+720.5%	$20.2M+741.7%	$11.6M-18.3%	$13.3M+37.1%	$4.4M+104.3%	$2.4M-84.3%
Net Income	$68.6M+8.5%	$102.2M+65.9%	$244.4M+1520.9%	$90.8M+968.2%	$63.2M-44.5%	$61.6M-35.0%	-$17.2M-117.6%	$8.5M-86.2%
EPS (Basic)	$0.59+15.7%	$0.85+70.0%	$2.05+2377.8%	$0.74+2366.7%	$0.51-15.0%	$0.500.0%	-$0.09-117.0%	$0.03-90.9%
EPS (Diluted)	$0.58+16.0%	$0.82+67.3%	$1.93	$0.73	$0.50	$0.49	-$0.07-114.3%	$0.03-90.6%
Diluted Shares (Avg)	119M+0.3%	122M+2.6%	N/A	119M	119M	119M	N/A	173M+2.5%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA.

SPNT Balance Sheet

SPNT quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$12.6B+0.4%	$12.5B-2.7%	$12.9B+16.6%	$11.0B+3.9%	$10.6B+200.4%	$3.5B+8.9%	$3.2B+5.2%	$3.1B-33.9%	$4.7B+19.9%	$3.9B+9.9%	$3.5B+24.3%	$2.9B+32.1%	$2.2B+54.1%	$1.4B	N/A
Cash & Equivalents	$731.2M+7.2%	$682.0M-29.6%	$969.2M+37.4%	$705.3M-29.5%	$999.8M+90.1%	$526.0M-17.7%	$639.4M+513.7%	$104.2M+1171.0%	$8.2M-17.6%	$10.0M-51.2%	$20.4M-29.0%	$28.7M-9.1%	$31.6M-7.0%	$34.0M-94.4%	$603.8M
Short-Term Investments	$28.3M-70.5%	$95.8M-74.2%	$371.6M-62.3%	$984.6M-8.5%	$1.1B	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	N/A	N/A	N/A	N/A	$14.5M	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Investments	$315.1M-0.4%	$316.5M+2.1%	$310.1M-17.8%	$377.2M-17.3%	$456.1M+11302.5%	$4.0M	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$10.1B-4.6%	$10.6B+2.4%	$10.3B+15.5%	$9.0B+10.3%	$8.1B+311.9%	$2.0B+7.6%	$1.8B-2.7%	$1.9B-35.2%	$2.9B+18.6%	$2.4B+13.8%	$2.1B+65.3%	$1.3B+100.2%	$649.5M+37.1%	$473.7M	N/A
Long-Term Debt	$688.6M+7.7%	$639.1M-18.7%	$786.2M+1.1%	$778.0M-4.7%	$816.7M+614.5%	$114.3M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$2.5B+27.5%	$1.9B-22.9%	$2.5B+21.2%	$2.1B-17.1%	$2.5B+60.1%	$1.6B+10.6%	$1.4B+17.4%	$1.2B-27.3%	$1.7B+17.1%	$1.4B+2.5%	$1.4B-5.0%	$1.5B-3.9%	$1.5B+62.7%	$928.3M+58.6%	$585.4M
Retained Earnings	$1.2B+56.5%	$784.9M+30.6%	$601.0M+129.2%	$262.2M-60.6%	$665.0M+7.2%	$620.4M+30.1%	$476.9M+72.6%	$276.3M-53.5%	$594.0M+87.8%	$316.2M+9.6%	$288.6M-23.2%	$376.0M+15.5%	$325.6M+231.3%	$98.3M	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$12.7B+2.4%	$12.5B+1.6%	$12.6B+0.4%	$12.5B-1.8%	$12.4B-3.2%	$12.3B-6.5%	$12.5B-2.7%	$12.7B+0.7%
Cash & Equivalents	$614.8M-16.1%	$856.9M+15.8%	$731.2M+7.2%	$582.4M-9.1%	$732.4M+22.5%	$740.3M-14.7%	$682.0M-29.6%	$640.7M-8.9%
Short-Term Investments	$7.5M-86.3%	$32.5M-32.6%	$28.3M-70.5%	$24.6M-53.1%	$54.9M-43.7%	$48.2M-85.4%	$95.8M-74.2%	$52.4M-90.5%
Long-Term Investments	$285.8M-10.7%	$295.4M-7.0%	$315.1M-0.4%	$318.3M+34.8%	$320.1M+32.4%	$317.7M+7.1%	$316.5M+2.1%	$236.1M-27.6%
Goodwill	$18.6M	$18.6M	$0	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$10.4B+1.2%	$10.2B-0.7%	$10.1B-4.6%	$10.2B+2.6%	$10.2B+1.9%	$10.3B-2.5%	$10.6B+2.4%	$10.0B-3.3%
Long-Term Debt	$675.5M-0.4%	$679.6M+2.4%	$688.6M+7.7%	$682.5M+3.3%	$678.4M+4.6%	$663.5M-13.9%	$639.1M-18.7%	$660.5M-13.5%
Total Equity	$2.3B+8.1%	$2.3B+13.7%	$2.5B+27.5%	$2.2B-18.0%	$2.1B-22.1%	$2.0B-22.2%	$1.9B-22.9%	$2.7B+19.8%
Retained Earnings	$1.4B+54.9%	$1.3B+57.6%	$1.2B+56.5%	$988.5M+22.6%	$901.7M+12.5%	$842.5M+21.8%	$784.9M+30.6%	$806.2M+58.9%

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities, Non-Current Liabilities.

SPNT Cash Flow Statement

SPNT quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$265.9M	$102.4M+37.1%	$74.7M-87.1%	$581.3M+98.2%	$293.3M+18231.3%	$1.6M-97.8%	$73.3M-48.1%	$141.1M+954.0%	$13.4M+117.0%	-$78.5M-1746.1%	$4.8M-97.5%	$187.8M+53.4%	$122.4M+521.2%	$19.7M+163.8%	-$30.9M-1886.6%	-$1.6M
Stock-Based Compensation	N/A	$35.9M+73.4%	$20.7M-3.3%	$21.4M-29.8%	$30.5M+167.5%	$11.4M+72.7%	$6.6M-5.7%	$7.0M+41.2%	$5.0M+37.7%	$3.6M-59.7%	$8.9M-17.8%	$10.9M+17.4%	$9.3M-5.5%	$9.8M+52.9%	$6.4M	N/A
Investing Cash Flow	-$144.0M	$424.2M+23.5%	$343.6M+203.4%	-$332.2M+74.5%	-$1.3B-725.3%	$208.6M+3376.7%	$6.0M-99.2%	$786.9M+108.4%	$377.6M+42.3%	$265.2M+411.1%	-$85.3M+48.0%	-$163.9M-37.7%	-$119.1M+72.1%	-$427.1M+47.0%	-$806.1M	$0
Financing Cash Flow	-$299.2M	-$518.8M+17.0%	-$625.0M-916.3%	-$61.5M-159.5%	-$23.7M-197.5%	$24.3M+225.3%	-$19.4M-254.0%	$12.6M+105.6%	-$226.9M-522.3%	$53.7M+41.2%	$38.1M+218.1%	-$32.2M-414.0%	-$6.3M-101.5%	$405.1M+51.6%	$267.2M-55.9%	$605.4M
Dividends Paid	$4.0M	$0	$0	$0	$0	$0	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$73.3M	$490.8M+63.8%	$299.7M	$0-100.0%	$5.0M	$0	$0	$0-100.0%	$138.7M+239.1%	$40.9M+452.7%	$7.4M	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$5.2M-108.4%	$141.9M+259.6%	-$26.4M-124.5%	$155.6M+167.8%	$62.1M+141.4%	-$88.9M-251.2%	$107.7M-49.5%	$58.1M-64.0%
Stock-Based Compensation	N/A	$10.5M+38.2%	N/A	N/A	N/A	$7.6M+85.4%	N/A	N/A
Investing Cash Flow	-$191.4M-324.4%	$189.0M-69.1%	$189.3M-6.8%	-$330.9M-263.7%	-$45.1M-336.1%	$610.9M+856.1%	$203.2M+222.0%	$202.1M+306.6%
Financing Cash Flow	-$68.2M-258.9%	-$222.6M+54.7%	-$1.8M+99.2%	-$6.6M+96.1%	-$19.0M+91.8%	-$491.4M-7021.1%	-$231.5M-1802.2%	-$169.0M-604.2%
Dividends Paid	$0-100.0%	$0	$0	$4.0M0.0%	$4.0M0.0%	$0	$0	$4.0M0.0%
Share Buybacks	$51.4M	$21.9M-95.5%	$0-100.0%	$0-100.0%	$0	$490.8M	$170.0M	$129.7M

Not reported in any period shown, so not listed: Depreciation & Amortization, Capital Expenditures, Free Cash Flow.

SPNT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SPNT quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Net Margin	14.3%+6.7pp	7.7%-5.3pp	13.0%+31.4pp	-18.4%-21.0pp	2.7%-13.5pp	16.1%-4.3pp	20.4%+106.3pp	-85.9%-115.4pp	29.6%+25.6pp	4.0%+19.2pp	-15.2%-24.7pp	9.5%-38.0pp	47.5%+4.9pp	42.6%	N/A
Return on Equity	18.6%+8.3pp	10.3%-3.8pp	14.1%+32.8pp	-18.6%-21.0pp	2.3%-6.9pp	9.2%-5.0pp	14.2%+40.6pp	-26.4%-43.1pp	16.8%+14.8pp	1.9%+8.3pp	-6.3%-9.8pp	3.5%-11.6pp	15.0%+4.3pp	10.7%+10.9pp	-0.2%
Return on Assets	3.7%+2.1pp	1.6%-1.2pp	2.8%+6.3pp	-3.5%-4.1pp	0.5%-3.5pp	4.1%-2.1pp	6.2%+16.5pp	-10.3%-16.2pp	5.9%+5.2pp	0.7%+3.2pp	-2.5%-4.2pp	1.8%-8.8pp	10.5%+3.4pp	7.1%	N/A
Debt-to-Equity	0.28-0.1x	0.330.0x	0.31-0.1x	0.380.0x	0.33+0.3x	0.07-1.2x	1.30-0.3x	1.56-0.2x	1.750.0x	1.73+0.2x	1.56+0.7x	0.90+0.5x	0.43-0.1x	0.51	N/A
Asset Turnover	0.260.0x	0.210.0x	0.210.0x	0.190.0x	0.210.0x	0.25-0.1x	0.30+0.2x	0.12-0.1x	0.200.0x	0.180.0x	0.160.0x	0.190.0x	0.22+0.1x	0.17	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Net Margin	9.2%+0.8pp	13.2%+4.7pp	25.1%+27.9pp	12.0%+10.5pp	8.5%-6.9pp	8.5%-5.4pp	-2.8%-17.9pp	1.5%-7.2pp
Return on Equity	3.0%0.0pp	4.4%+1.4pp	9.9%+10.8pp	4.1%+3.8pp	3.0%-1.2pp	3.0%-0.6pp	-0.9%-4.8pp	0.3%-2.4pp
Return on Assets	0.5%0.0pp	0.8%+0.3pp	1.9%+2.1pp	0.7%+0.7pp	0.5%-0.4pp	0.5%-0.2pp	-0.1%-0.9pp	0.1%-0.4pp
Debt-to-Equity	0.300.0x	0.300.0x	0.28-0.1x	0.31+0.1x	0.32+0.1x	0.330.0x	0.330.0x	0.25-0.1x
Asset Turnover	0.060.0x	0.060.0x	0.080.0x	0.060.0x	0.060.0x	0.060.0x	0.050.0x	0.040.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
SiriusPoint Ltd. SPNT	FY2025	$3.2B	$460.0M	14.3%	$2.9B	34/100
Hamilton Insurance Group, Ltd. HG	FY2025	$2.9B	$840.0M	28.9%	$3.4B	44/100
Everest Group, Ltd. EG	FY2025	$17.5B	$1.6B	9.1%	$13.9B	38/100
RenaissanceRe Holdings Ltd. RNR	FY2025	$12.8B	$2.7B	20.9%	$13.4B	50/100
Reinsurance Group of America, Incorporated RGA	FY2025	$23.7B	$1.2B	5.0%	$16.4B	23/100
Greenlight Captial RE, LTD. GLRE	FY2025	$729.8M	$74.8M	10.3%	$482.1M	47/100

Where SiriusPoint Ltd. Ranks

Frequently Asked Questions

What is SiriusPoint Ltd.'s annual revenue?

SiriusPoint Ltd. (SPNT) reported $3.2B in total revenue for fiscal year 2025. This represents a 23.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is SiriusPoint Ltd.'s revenue growing?

SiriusPoint Ltd. (SPNT) revenue grew by 23.1% year-over-year, from $2.6B to $3.2B in fiscal year 2025.

Is SiriusPoint Ltd. profitable?

Yes, SiriusPoint Ltd. (SPNT) reported a net income of $460.0M in fiscal year 2025, with a net profit margin of 14.3%.

How much debt does SiriusPoint Ltd. have?

As of fiscal year 2025, SiriusPoint Ltd. (SPNT) had $731.2M in cash and equivalents against $688.6M in long-term debt.

What is SiriusPoint Ltd.'s net profit margin?

SiriusPoint Ltd. (SPNT) had a net profit margin of 14.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is SiriusPoint Ltd.'s return on equity (ROE)?

SiriusPoint Ltd. (SPNT) has a return on equity of 18.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is SiriusPoint Ltd.'s operating cash flow?

SiriusPoint Ltd. (SPNT) generated $102.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are SiriusPoint Ltd.'s total assets?

SiriusPoint Ltd. (SPNT) had $12.6B in total assets as of fiscal year 2025, including both current and long-term assets.

Does SiriusPoint Ltd. buy back shares?

Yes, SiriusPoint Ltd. (SPNT) spent $490.8M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does SiriusPoint Ltd. have outstanding?

SiriusPoint Ltd. (SPNT) had 117M shares outstanding as of fiscal year 2025.

What is SiriusPoint Ltd.'s debt-to-equity ratio?

SiriusPoint Ltd. (SPNT) had a debt-to-equity ratio of 0.28 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is SiriusPoint Ltd.'s return on assets (ROA)?

SiriusPoint Ltd. (SPNT) had a return on assets of 3.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is SiriusPoint Ltd.'s P/E ratio?

SiriusPoint Ltd. (SPNT) trades at 5.7x earnings, its market capitalization divided by net income of $506.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $2.9B as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is SiriusPoint Ltd.'s price-to-sales ratio?

SiriusPoint Ltd. (SPNT) trades at 0.9x sales, its market capitalization divided by revenue of $3.2B revenue, trailing 12 months to June 30, 2026. The market capitalization is $2.9B as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is SiriusPoint Ltd.'s Piotroski F-Score?

SiriusPoint Ltd. (SPNT) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are SiriusPoint Ltd.'s earnings high quality?

SiriusPoint Ltd. (SPNT) has an earnings quality ratio of 0.22x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is SiriusPoint Ltd.?

SiriusPoint Ltd. (SPNT) scores 34 out of 100 on our Financial Health Score, indicating weak standing within its insurers peer group. The score is a 0-100 composite of six dimensions (Loss Ratio, Premium Growth, Capital, Investment Yield, Combined Ratio, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.